MolPort

About:

MolPort distributes chemical compounds to biotech researchers and the scientific community.

Website: http://www.molport.com

Twitter/X: molport

Top Investors: FlyCap, Imprimatur Capital Fund Management

Description:

MolPort sells existing chemical compounds to biotech researchers and the scientific community to speed up drug discovery. Whether it is for biological testing or a reagent to make a key target compound, effectively accessing commercial compounds is a core component of efficient drug discovery. MolPort was created in 2006 to help scientists accelerate drug discovery by handling the ordering process of screening compounds and building blocks. Our goal is to help scientists focus on their research, not on procurement. Compound sourcing is a very specific job that requires very specialized expertise and software tools. MolPort specializes in sourcing hundreds or thousands of compounds from dozens of suppliers.

Total Funding Amount:

1.09M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Riga, Riga, Latvia

Founded Date:

2006-12-01

Contact Email:

sales(AT)molport.com

Founders:

Imants Zudans

Number of Employees:

11-50

Last Funding Date:

2015-01-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai